Skip to content
healthcare.dev

CERAMIDE LIFT and FIRM

NDC 10967-666, Octinoxate, Oxybenzone, Avobenzone, Octisalate, Octocrylene, emulsion, from REVLON.

Product NDC
10967-666
Status
Listed
Labeler
REVLON
Dosage form
EMULSION
Route
TOPICAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M020
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/10967-666 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OXYBENZONE5 mg/g
  • OCTISALATE5 mg/g
  • OCTINOXATE7.5 mg/g
  • OCTOCRYLENE2.2 mg/g
Package NDCNDC-11Package
10967-666-171096706661749 g in 1 JAR (10967-666-17)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 10967-666 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/10967-666 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 10967-666. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.